Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
Recruiting · NCT06210854 · Registry updated 2026-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 2 | 2026-07-01 | NCT06210854 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| PapiVax Biotech, Inc. | 5 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 117 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Johns Hopkins University | Baltimore | United States | 150 |
| University of Alabama at Birmingham | Birmingham | United States | 35 |